Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits - PubMed (original) (raw)

Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits

K H Holt et al. Mol Cell Biol. 1994 Jan.

Abstract

Domains of interaction between the p85 and p110 subunits of phosphatidylinositol 3-kinase (PI 3-kinase) were studied with the yeast two-hybrid expression system. A gene fusion between the GAL4 transactivation domain and p85 activated transcription from a GAL1-lacZ reporter gene when complemented with a gene fusion between the GAL4 DNA binding domain and p110. To define subdomains responsible for this interaction, a series of p85 deletion mutants were analyzed. A 192-amino-acid inter-SH2 (IS) fragment (residues 429 to 621) was the smallest determinant identified that specifically associated with p110. In analogous experiments, the subdomain within p110 responsible for interaction with p85 was localized to an EcoRI fragment encoding the amino-terminal 127 residues. Expression of these two subdomains [p85(IS) with p110RI] resulted in 100-fold greater reporter activity than that obtained with full-length p85 and p110. Although the p85(IS) domain conferred a strong interaction with the p110 catalytic subunit, this region was not sufficient to impart phosphotyrosine peptide stimulation of PI 3-kinase activity. In contrast, coexpression of the p110 subunit with full-length p85 or with constructs containing the IS sequences flanked by both SH2 domains of p85 [p85(n/cSH2)] or either of the individual SH2 domains [p85(nSH2+IS) or p85(IS+cSH2)] resulted in PI 3-kinase activity that was activated by a phosphotyrosine peptide. These data suggest that phosphotyrosine peptide binding to either SH2 domain generates an intramolecular signal propagated through the IS region to allosterically activate p110.

PubMed Disclaimer

Cited by

The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
Fu Z, Aronoff-Spencer E, Backer JM, Gerfen GJ. Fu Z, et al. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3275-80. doi: 10.1073/pnas.0535975100. Epub 2003 Mar 10. Proc Natl Acad Sci U S A. 2003. PMID: 12629217 Free PMC article.
The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.
Arcaro A, Guerreiro AS. Arcaro A, et al. Curr Genomics. 2007 Aug;8(5):271-306. doi: 10.2174/138920207782446160. Curr Genomics. 2007. PMID: 19384426 Free PMC article.
Novel mobilizable prokaryotic two-hybrid system vectors for high-throughput protein interaction mapping in Escherichia coli by bacterial conjugation.
Clarke P, Cuív PO, O'Connell M. Clarke P, et al. Nucleic Acids Res. 2005 Feb 1;33(2):e18. doi: 10.1093/nar/gni011. Nucleic Acids Res. 2005. PMID: 15687376 Free PMC article.
Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.
Vanhaesebroeck B, Higashi K, Raven C, Welham M, Anderson S, Brennan P, Ward SG, Waterfield MD. Vanhaesebroeck B, et al. EMBO J. 1999 Mar 1;18(5):1292-302. doi: 10.1093/emboj/18.5.1292. EMBO J. 1999. PMID: 10064595 Free PMC article.
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.
Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S. Jaiswal BS, et al. Cancer Cell. 2009 Dec 8;16(6):463-74. doi: 10.1016/j.ccr.2009.10.016. Cancer Cell. 2009. PMID: 19962665 Free PMC article.

References

1. Cell. 1990 Apr 20;61(2):203-12 - PubMed
1. Science. 1990 Mar 30;247(4950):1578-81 - PubMed
1. Eur J Biochem. 1990 Aug 17;191(3):761-7 - PubMed
1. J Biol Chem. 1990 Nov 15;265(32):19704-11 - PubMed
1. Cell. 1991 Jan 25;64(2):281-302 - PubMed

Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits - PubMed (original) (raw)